Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 4/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.40 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 3/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17640580 | 0.97 | CYP19A1 (0.45) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL17640576 | 0.97 | CYP19A1 (0.45) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL17640612 | 0.91 | CYP19A1 (0.40) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL21915416 | 0.90 | HDAC6 (0.41) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL21915628 | 0.90 | CYP19A1 (0.40) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL21915393 | 0.89 | CYP19A1 (0.39) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL21915428 | 0.89 | HSD17B1 (0.40) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL17640569 | 0.87 | CYP19A1 (0.51) | CYP19A1MAPTHSD17B1HSD17B2SNCA | |
| SCHEMBL21915474 | 0.86 | HSD17B1 (0.39) | CYP19A1HDAC6MAPTHSD17B1HSD17B2 | |
| SCHEMBL21915567 | 0.86 | HDAC6 (0.49) | CYP19A1HDAC6MAPTMAOAADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020062375-A1 | 1,2,4-THIADIAZOLE COMPOUNDS AND PREPARATION METHOD THEREFOR AND USE THEREOF | 武汉尚赛光电科技有限公司 | 2020-04-02 | — | — | WO | disclosed |
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | UDC IRELAND LIMITED (IE) | 2019-06-25 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| WO-2016046350-A1 | FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY | BASF SE (DE) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10333078-B2 | Fluorescent organic light emitting elements having high efficiency | NR2E3, CRY1, ALDH1A2 | CYP19A1 2245/4885HDAC6 3454/4885MAPT 2708/4885 |
| US-20170309828-A1 | Fluorescent Organic Light Emitting Elements Having High Efficiency | NR2E3, CRY1, ALDH1A2 | CYP19A1 2245/4885HDAC6 3454/4885MAPT 2708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.